| Epsilonproteobacteria in humans, New Zealand. | |
| | |
| Jump to Full Text | |
MedLine Citation:
|
PMID: 23017215 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Susan Bullman; Daniel Corcoran; James O'Leary; Deirdre Byrne; Brigid Lucey; Roy D Sleator |
Related Documents
:
|
22924975 - Performance of matrix-assisted laser desorption-time of flight mass spectrometry for id... 23079725 - Methods for robust in vivo strain estimation in the carotid artery. 22360305 - Aureocin a70 production is disseminated amongst genetically-unrelated staphylococcus au... 23149515 - Dispersal of bap-mediated staphylococcus aureus biofilm by proteinase k. 22767545 - The suhb gene of burkholderia cenocepacia is required for protein secretion, biofilm fo... 12732565 - Isolation and characterization of novel psychrophilic, neutrophilic, fe-oxidizing, chem... |
Publication Detail:
|
Type: Comment; Letter |
Journal Detail:
|
Title: Emerging infectious diseases Volume: 18 ISSN: 1080-6059 ISO Abbreviation: Emerging Infect. Dis. Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-09-28 Completed Date: 2013-02-19 Revised Date: 2013-04-08 |
Medline Journal Info:
|
Nlm Unique ID: 9508155 Medline TA: Emerg Infect Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 1709-10; author reply 1710-1 Citation Subset: IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Epsilonproteobacteria
/
classification*,
genetics* Humans |
| Comments/Corrections | |
Comment On:
|
Emerg Infect Dis. 2012 Mar;18(3):510-2
[PMID:
22377283
]
|
| Full Text | |
|
Journal Information Journal ID (nlm-ta): Emerg Infect Dis Journal ID (iso-abbrev): Emerging Infect. Dis Journal ID (publisher-id): EID ISSN: 1080-6040 ISSN: 1080-6059 Publisher: Centers for Disease Control and Prevention |
Article Information Download PDF ![]() Print publication date: Month: 10 Year: 2012 Volume: 18 Issue: 10 First Page: 1709 Last Page: 1710 PubMed Id: 23017215 ID: 3479867 Publisher Id: 12-0369 DOI: 10.3201/eid1810.120369 |
| Epsilonproteobacteria in Humans, New Zealand Alternate Title:Epsilonproteobacteria in Humans | |
| Susan Bullman | |
| Daniel Corcoran | |
| James O’Leary | |
| Deirdre Byrne | |
| Brigid Lucey | |
| Roy D. Sleator | |
| Cork Institute of Technology, Cork, Ireland (S. Bullman, B. Lucey, R.D. Sleator); |
|
| and Cork University Hospital, Cork (D. Corcoran, J.O’Leary, D. Byrne, B. Lucey) |
|
| Correspondence: Address for correspondence: Brigid Lucey, Department of Medical Microbiology, Cork University Hospital, Wilton, Cork, Ireland; email: brigid.lucey@cit.ie |
|
To the Editor: Cornelius et al. (1) addressed the potential of Campylobacter ureolyticus as an emerging pathogen by conducting a molecular study on 128 diarrheal specimens and 49 fecal samples from healthy volunteers. Reporting the identification of C. ureolyticus in 12 (24.5%) of 49 healthy volunteers, a number that they compared with our finding of 349 (23.8%) from Campylobacter spp.–positive samples (2), the authors concluded that C. ureolyticus species “are unlikely causes of diarrhea,” an assertion with which we take issue.
This interpretation does not take into account that our screening involved 7,194 symptomatic patients: a sample size 40× greater than that of Cornelius et al. In this context, the likely carriage rate for C. ureolyticus is 1.15%. Also, our assay, which has a limit of detection in the picomolar range, is likely comparable with, if not greater than, that of Cornelius et al. (1).
Accounting for variations in geographic location and detection methods, a detection rate of 24.5% in healthy volunteers (overall detection rate 14.7%) is high in contrast to our reported rate of 1.15%. One possible explanation for this discrepancy is that Cornelius et al. “did not specifically exclude volunteers who had had gastrointestinal disturbances in the 10 days before sampling,” Campylobacter can be shed in feces for <4 weeks after infection. Also, Cornelius et al. (1) noted the possibility of “genetically distinct but phenotypically indistinguishable genomospecies differing in their pathogenic potential” to account for the presence of the emerging pathogen C. concisus in healthy volunteers and patients with diarrheal illness. This may also apply for C. ureolyticus.
We reported a strong seasonal prevalence of C. ureolytcius and a bimodal age distribution (2). The lack of any related details from Cornelius et al. may undermine their reported detection rates. These factors strongly suggest that the statement, “these species are unlikely causes of diarrhea,” should, at the very least, be taken under advisement.
Notes
Suggested citation for this article: Bullman S, Corcoran D, O’Leary J, Byrne D, Lucey B, Sleator R. Epsilonproteobacteria in humans, New Zealand [letter]. Emerg Infect Dis [Internet]. 2012 Oct [date cited]. http://dx.doi.org/10.3201/eid1810.120369
| 1. . | CorneliusAJ, ChambersS, AitkenJ, BrandtSM, HornB, OnSLEpsilonproteobacteria in humans, New Zealand.Emerg Infect Dis. Year: 2012;18:510–210.3201/eid1803.11087522377283 |
| 2. . | BullmanS, CorcoranD, O’LearyJ, O’HareD, LuceyB, SleatorRDEmerging dynamics of human campylobacteriosis in southern Ireland.FEMS Immunol Med Microbiol. Year: 2011;63:248–5310.1111/j.1574-695X.2011.00847.x22077228 |
Article Categories:
Keywords: Keywords: Campylobacter, ureolyticus, Epsilonproteobacteria, Helicobacter, Arcobacter, PCR, epidemiology, volunteers, diarrhea, molecular, diagnostic, bacteria, New Zealand. |
|
Previous Document: Identification of genes containing ecdysone response elements in the genome of Brugia malayi.
Next Document: In-Situ Revascularisation for Secondary Aorto-enteric Fistulae: The Success of Silver-coated Dacron ...
